Free Trial

Bellevue Healthcare (LON:BBH) Stock Crosses Below 50 Day Moving Average - Here's What Happened

Bellevue Healthcare logo with Financial Services background
Remove Ads

Bellevue Healthcare (LON:BBH - Get Free Report)'s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 142.77 ($1.84) and traded as low as GBX 128.20 ($1.65). Bellevue Healthcare shares last traded at GBX 128.80 ($1.66), with a volume of 9,881,537 shares changing hands.

Bellevue Healthcare Stock Performance

The stock has a market capitalization of £308.07 million and a price-to-earnings ratio of -19.01. The company's 50 day moving average is GBX 142.51 and its 200 day moving average is GBX 143.78.

About Bellevue Healthcare

(Get Free Report)

Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.

Read More

Should You Invest $1,000 in Bellevue Healthcare Right Now?

Before you consider Bellevue Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bellevue Healthcare wasn't on the list.

While Bellevue Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads